SEC Form 4 · accession 0001144204-17-047126
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Larry Lee Miller
Officer — Chief Operating Officer
Period of report
Sep 5, 2017
Accepted (ET)
Sep 7, 2017 · 9:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Sep 5, 2017 | M | 4,237 | $11.83 | A | 4,237 | D | |
| Class A Common StockF2 | Sep 5, 2017 | S | 4,237 | $35.55 | D | 0 | D | |
| Class A Common Stock | Sep 5, 2017 | M | 810 | $11.83 | A | 810 | D | |
| Class A Common StockF3 | Sep 5, 2017 | S | 810 | $36.49 | D | 0 | D | |
| Class A Common Stock | Sep 6, 2017 | M | 8,587 | $11.83 | A | 8,587 | D | |
| Class A Common StockF4 | Sep 6, 2017 | S | 8,587 | $34.97 | D | 0 | D | |
| Class A Common Stock | Sep 7, 2017 | M | 8,236 | $11.83 | A | 8,236 | D | |
| Class A Common StockF5 | Sep 7, 2017 | S | 8,236 | $35.68 | D | 0 | D | |
| Class A Common Stock | Sep 7, 2017 | M | 10,589 | $11.83 | A | 10,589 | D | |
| Class A Common StockF6 | Sep 7, 2017 | S | 10,589 | $35.96 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Common Stock | $11.83 | Sep 5, 2017 | M | 5,047 | D | Apr 29, 2013 | Feb 28, 2019 | Class A Common Stock | 5,047 | 167,453 | D |
| Option to purchase Common Stock | $11.83 | Sep 6, 2017 | M | 8,587 | D | Apr 29, 2013 | Feb 28, 2019 | Class A Common Stock | 8,587 | 158,866 | D |
| Option to purchase Common Stock | $11.83 | Sep 7, 2017 | M | 18,825 | D | Apr 29, 2013 | Feb 28, 2019 | Class A Common Stock | 18,825 | 140,041 | D |
Explanation of responses
- F1The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.20 to $36.10, inclusive.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.35 to $36.65, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.70 to $35.20, inclusive.
- F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.90 to $35.88, inclusive.
- F6The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.90 to $36.10, inclusive.